JP2024502446A5 - - Google Patents
Info
- Publication number
- JP2024502446A5 JP2024502446A5 JP2023541058A JP2023541058A JP2024502446A5 JP 2024502446 A5 JP2024502446 A5 JP 2024502446A5 JP 2023541058 A JP2023541058 A JP 2023541058A JP 2023541058 A JP2023541058 A JP 2023541058A JP 2024502446 A5 JP2024502446 A5 JP 2024502446A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- subject
- composition according
- compound
- lung cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163135449P | 2021-01-08 | 2021-01-08 | |
| US63/135,449 | 2021-01-08 | ||
| US202163189625P | 2021-05-17 | 2021-05-17 | |
| US63/189,625 | 2021-05-17 | ||
| PCT/US2022/011673 WO2022150628A1 (en) | 2021-01-08 | 2022-01-07 | Use of a kras g12c inhibitor in treating cancers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502446A JP2024502446A (ja) | 2024-01-19 |
| JP2024502446A5 true JP2024502446A5 (https=) | 2025-01-15 |
Family
ID=80222156
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023541058A Pending JP2024502446A (ja) | 2021-01-08 | 2022-01-07 | 癌の治療におけるｋｒａｓ ｇ１２ｃ阻害剤の使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240091230A1 (https=) |
| EP (2) | EP4274579A1 (https=) |
| JP (1) | JP2024502446A (https=) |
| AU (1) | AU2022205969A1 (https=) |
| CA (1) | CA3206523A1 (https=) |
| MX (1) | MX2023007918A (https=) |
| TW (1) | TWI906448B (https=) |
| WO (1) | WO2022150628A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195609A2 (en) | 2018-04-04 | 2019-10-10 | Arvinas Operations, Inc. | Modulators of proteolysis and associated methods of use |
| CA3098574A1 (en) | 2018-05-04 | 2019-11-07 | Amgen Inc. | Kras g12c inhibitors and methods of using the same |
| US12122787B2 (en) | 2019-09-20 | 2024-10-22 | Shanghai Jemincare Pharmaceuticals Co., Ltd | Fused pyridone compound, and preparation method therefor and use thereof |
| US12448399B2 (en) | 2023-01-26 | 2025-10-21 | Arvinas Operations, Inc. | Cereblon-based KRAS degrading PROTACs and uses related thereto |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2018273356B2 (en) | 2017-05-22 | 2021-09-16 | Amgen Inc. | KRAS G12C inhibitors and methods of using the same |
| EP3738593A1 (en) * | 2019-05-14 | 2020-11-18 | Amgen, Inc | Dosing of kras inhibitor for treatment of cancers |
| WO2020236947A1 (en) | 2019-05-21 | 2020-11-26 | Amgen Inc. | Solid state forms |
-
2022
- 2022-01-07 MX MX2023007918A patent/MX2023007918A/es unknown
- 2022-01-07 JP JP2023541058A patent/JP2024502446A/ja active Pending
- 2022-01-07 WO PCT/US2022/011673 patent/WO2022150628A1/en not_active Ceased
- 2022-01-07 US US18/270,581 patent/US20240091230A1/en active Pending
- 2022-01-07 CA CA3206523A patent/CA3206523A1/en active Pending
- 2022-01-07 TW TW111100657A patent/TWI906448B/zh active
- 2022-01-07 EP EP22703115.0A patent/EP4274579A1/en not_active Withdrawn
- 2022-01-07 EP EP25206294.8A patent/EP4650006A3/en active Pending
- 2022-01-07 AU AU2022205969A patent/AU2022205969A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022009090A5 (https=) | ||
| JP2024502446A5 (https=) | ||
| JP2024133475A5 (https=) | ||
| JP2022537551A5 (https=) | ||
| CN103945849B (zh) | 癌症的联合治疗 | |
| JP2024540015A5 (https=) | ||
| JP2024015120A5 (https=) | ||
| CN114641293A (zh) | 一种fgfr抑制剂的用途 | |
| JP2019532051A5 (https=) | ||
| JP2019503365A5 (https=) | ||
| CN101360495B (zh) | 对癌症病人给药mTOR抑制剂 | |
| BRPI0915284B1 (pt) | composição farmacêutica oral, e, uso de uma composição farmacêutica | |
| JP2023546362A5 (https=) | ||
| JP2021504384A5 (https=) | ||
| JP2023548055A5 (https=) | ||
| CN103533940A (zh) | 治疗晚期实体瘤的方法 | |
| WO2017118401A1 (zh) | 喹啉衍生物用于治疗食管癌的用途及其治疗方法、药物组合物和试剂盒 | |
| WO2015185011A1 (zh) | 喹啉衍生物用于治疗甲状腺癌的方法和用途以及用于治疗甲状腺癌的药物组合物 | |
| JP2023522716A5 (https=) | ||
| TWI760306B (zh) | 供治療癌症之口服投予紫杉醇及Ｐ-ｇｐ抑制劑的治療性組合 | |
| JP2023522415A5 (https=) | ||
| JP2004525143A5 (https=) | ||
| JP2025509278A5 (https=) | ||
| JP2022521173A5 (https=) | ||
| WO2008035461A1 (fr) | Chimiothérapie adjuvante post-opératoire pour un cancer gastrique |